Yersinia Pseudotuberculosis Septicemia and HIV

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2005 Jul 19

PMID 16022797

Citations 5

Authors

Maria Grazia Paglia

Silvia DArezzo

Anna Festa

Cosmo Del Borgo

Laura Loiacono

Andrea Antinori

Giorgio Antonucci

Paolo Visca

Affiliations

Soon will be listed here.

Abstract

Two cases of community-acquired septicemia caused by serotype-O1 Yersinia pseudotuberculosis were diagnosed in middle-aged, HIV-positive, immunodeficient patients during an 8-month period. Bacterial isolates were genetically indistinguishable, but no epidemiologic link between the 2 patients was established. HIV-related immunosuppression should be regarded as a risk factor for Y. pseudotuberculosis septicemia.

Citing Articles

Liver abscess and splenic infarction due to Yersinia pseudotuberculosis bloodstream infection: a case report.

Wang Y, Xiang Y, Lei C, Zheng X, Wu W, Zhang Z BMC Infect Dis. 2024; 24(1):1415.

PMID: 39695397 PMC: 11654157. DOI: 10.1186/s12879-024-10325-z.

Case report: First isolation of from the blood of a cat.

Scarpellini R, Giunti M, Bulgarelli C, Mondo E, Esposito E, Assirelli G Front Vet Sci. 2024; 10:1261925.

PMID: 38249564 PMC: 10796726. DOI: 10.3389/fvets.2023.1261925.

Extraintestinal Manifestation of Bacteremia as Acute Hepatitis: Case Report and Review of the Literature.

Lee Y, Kim J, Jeon J, Seok H, Choi W, Chang E Pathogens. 2021; 10(10).

PMID: 34684204 PMC: 8539584. DOI: 10.3390/pathogens10101255.

The Cytotoxic Necrotizing Factor of Yersinia pseudotuberculosis (CNFy) is Carried on Extracellular Membrane Vesicles to Host Cells.

Monnappa A, Bari W, Seo J, Mitchell R Sci Rep. 2018; 8(1):14186.

PMID: 30242257 PMC: 6155089. DOI: 10.1038/s41598-018-32530-y.

Yersinia pseudotuberculosis bloodstream infection and septic arthritis: case report and review of the literature.

Kaasch A, Dinter J, Goeser T, Plum G, Seifert H Infection. 2011; 40(2):185-90.

PMID: 21789525 DOI: 10.1007/s15010-011-0160-2.

References

Yao T, Mecsas J, Healy J, Falkow S, Chien Y . Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med. 1999; 190(9):1343-50. PMC: 2195683. DOI: 10.1084/jem.190.9.1343. View

Fukushima H, Matsuda Y, Seki R, Tsubokura M, Takeda N, Shubin F . Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol. 2001; 39(10):3541-7. PMC: 88386. DOI: 10.1128/JCM.39.10.3541-3547.2001. View

Carnoy C, Floquet S, Marceau M, Sebbane F, Devalckenaere A, Simonet M . The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis. J Bacteriol. 2002; 184(16):4489-99. PMC: 135243. DOI: 10.1128/JB.184.16.4489-4499.2002. View

Cornelis G . Yersinia type III secretion: send in the effectors. J Cell Biol. 2002; 158(3):401-8. PMC: 2173816. DOI: 10.1083/jcb.200205077. View

Deacon A, Hay A, Duncan J . Septicemia due to Yersinia pseudotuberculosis--a case report. Clin Microbiol Infect. 2003; 9(11):1118-9. DOI: 10.1046/j.1469-0691.2003.00746.x. View

Monnazzi L, Carlos I, de Medeiros B . Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages. Immunol Lett. 2004; 94(1-2):91-8. DOI: 10.1016/j.imlet.2004.04.007. View

Abe J, Onimaru M, Matsumoto S, Noma S, Baba K, Ito Y . Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest. 1997; 99(8):1823-30. PMC: 508006. DOI: 10.1172/JCI119349. View

CANNON C, Linnemann Jr C . Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections. Infect Control Hosp Epidemiol. 1992; 13(3):139-43. DOI: 10.1086/646496. View

Chiesa C, Pacifico L, Nanni F, Renzi A, Ravagnan G . Yersinia pseudotuberculosis in Italy. Attempted recovery from 37,666 samples. Microbiol Immunol. 1993; 37(5):391-4. DOI: 10.1111/j.1348-0421.1993.tb03226.x. View

10.

Makino S, Okada Y, Maruyama T, Kaneko S, Sasakawa C . PCR-based random amplified polymorphic DNA fingerprinting of Yersinia pseudotuberculosis and its practical applications. J Clin Microbiol. 1994; 32(1):65-9. PMC: 262971. DOI: 10.1128/jcm.32.1.65-69.1994. View

11.

Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M . AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 1995; 23(21):4407-14. PMC: 307397. DOI: 10.1093/nar/23.21.4407. View

12.

Ljungberg P, Valtonen M, Harjola V, Vaara M . Report of four cases of Yersinia pseudotuberculosis septicemia and a literature review. Eur J Clin Microbiol Infect Dis. 1995; 14(9):804-10. DOI: 10.1007/BF01690998. View

13.

Tabacchioni S, Visca P, Chiarini L, Bevivino A, Di Serio C, Fancelli S . Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol. 1995; 146(7):531-42. DOI: 10.1016/0923-2508(96)80559-6. View

14.

Antinori A, Paglia M, Marconi P, Festa A, Alba L, Boumis E . Short Communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART. AIDS Res Hum Retroviruses. 2004; 20(7):709-10. DOI: 10.1089/0889222041524599. View